Although detailed pathophysiological mechanisms of fulminant hepatitis remain elusive, immune cell recruitment with excessive cytokine production is a well-recognized hallmark of the disease. We determined the function of orphan nuclear receptor small heterodimer partner (SHP) in concanavalin A (ConA)-induced hepatitis model. Male C57BL/6 J mice were injected intravenously with either a lethal dose (25 mg/kg) or a sub-lethal dose (15 mg/kg) of ConA. For the C-X-C motif chemokine ligand (CXCL) 2 neutralization study, mice were intravenously administered anti-mouse CXCL2 antibody (100 lg/mouse). Thirtysix hours following lethal dose of ConA administration, 47% wild type (WT) mice were alive, whereas >85% of Shp knockout (KO) were dead. Shp KO mice were highly susceptible to ConA-induced liver injury and exhibited increased liver necrosis upon sublethal dose of ConA administration. FACS analysis and immunohistochemical staining showed significantly higher neutrophil infiltration in Shp KO mice, as compared with WT mice. We found that also in the WT situation, Shp expression gradually decreased, while Cxcl2 expression increased until 6 h, and vice versa at 24 h upon ConA-treatment, indicating an inverse correlation between Shp and Cxcl2 expression during ConA-induced hepatitis. Furthermore, in vivo neutralization of CXCL2 with neutralizing antibody reduces ConA-induced plasma ALT and AST levels, hepatocyte death and neutrophil infiltration in Shp KO
Concanavalin A (ConA) administration in mice induces strong innate inflammation, massive hepatic necrosis, and liver failure (Herkel et al., 2005) , and is thus considered a well-characterized model of human fulminant hepatitis (Erhardt et al., 2007; Hoffmann et al., 2009 ). In this model, the innate immune system is driven by a complex set of immune cells and anti-microbial proteins, including natural killer cells, natural killer T cells, dendritic cells, neutrophils, eosinophils, and complement components (Bonder et al., 2004; Kremer et al., 2008; Miyagi et al., 2004; Tomiyama et al., 2011) . Recruiting neutrophils to damaged organ regions, ie, liver, is considered a double-edged sword (Xu et al., 2014) . On the one hand, neutrophils have a pivotal role in the primary defense against initial internal and/or external attacks (Kolaczkowska and Kubes, 2013) . On the other hand, excessive neutrophil infiltration and activation also may cause severe liver damage (Kolaczkowska et al., 2015) . To understand the mechanism of inflammation-driven severe liver injury such as fulminant hepatitis, functional characterization of factors that regulate neutrophil recruitment to the liver is a key issue.
Chemokines are a family of chemotactic cytokines that mediate immune cell trafficking and function (Oppenheim et al., 1991) . They are small (8-10 kD), basic, heparin-binding proteins that are secreted by immune cells as well as various tissue parenchymal cells (Baggiolini, 2001; Miller and Krangel, 1992) . CXC subfamily chemokines, especially CXCL1 (keratinocyte-derived chemokine) and CXCL2 (macrophage inflammation protein-2), are crucial for neutrophil recruitment to sites of inflammation following hepatic injury (Marra and Tacke, 2014) . However, knowledge on mechanisms modulating expression and function of CXC chemokines in fulminant hepatitis is limited.
Small heterodimer partner (SHP, NR0B2) is a unique nuclear receptor (NR) that is distinct from conventional NRs in both structure and function (Seol et al., 1996) . Because no endogenous ligands have been identified, SHP belongs to the "orphan" subfamily. SHP acts as transcriptional corepressor of gene expression through direct binding to a variety of NRs (Zhang et al., 2011) . In healthy and damaged liver, the functions of SHP in regulating bile acid synthesis, lipid, and glucose homeostasis (Chanda et al., 2008; Goodwin et al., 2000) and cancer development (Zhang et al., 2008) have been well documented. In contrast, not much is known about regulatory roles of SHP in inflammatory diseases. Just recently, we found that SHP indeed may regulate immune response, since SHP-deficient mice show increased susceptibility for endotoxin-induced septic shock (Yuk et al., 2011) . Furthermore, SHP physically and functionally may interact with the NLRP3 inflammasome to interfere with its activation (Yang et al., 2015) . Nevertheless, whether and how SHP contributes to innate inflammation in fulminant hepatitis is unknown to date.
In this study, we analyzed whether SHP has impact on severity of hepatitis development in the ConA-evoked liver inflammation model.
MATERIALS AND METHODS
Animal studies. Eight-week-old male Shp knockout (KO) mice with a C57BL/6 background and wild type (WT) C57BL/6 control mice were obtained from the Korea Research Institute of Bioscience and Biotechnology (KRIBB; Daejeon, Korea). The mice were injected intravenously with either a lethal dose (25 mg/kg) or a sub-lethal dose (15 mg/kg) of ConA (Sigma-Aldrich Chemical, St Louis, Missouri). For the neutrophil depletion study, mice were injected anti-Ly6G or isotype control antibody (500 mg/mouse; BioXcell, Lebanon, New Hampshire) 12 h and 30 min before ConA administration. Neutrophil depletion were confirmed by flow cytometry using peripheral blood (Supplementary Figure 1) . For the CXCL2 neutralization study, mice were intravenously administered anti-mouse CXCL2 or control antibody (both 100 mg/mouse; R&D Systems, Minneapolis, Minnesota) 30 min before ConA injection. All animal experiments were approved by the Institutional Animal Use and Care Committee of the Korea Research Institute of Bioscience and Biotechnology and were performed in accordance with the Guide for the Care and Use of Laboratory Animals published by the U.S. National Institutes of Health.
Blood analysis. Plasma alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were determined with an automated blood chemistry analyzer (Hitachi 7150; Hitachi, Tokyo, Japan).
Histopathology and immunohistochemistry. Liver samples were fixed in 10% neutral buffered formalin, embedded in paraffin, cut into 5-lm-thick sections, and stained with Hematoxylin & eosin (H&E). To detect neutrophil infiltration, liver sections were stained with an anti-neutrophil antibody (NIMP-R14, Abcam, Cambridge, Massachusetts) and visualized using 3, 3 0 -diaminobenzidine (Vector Lab, Burlingame, California).
Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining. TUNEL staining was performed using paraffinembedded tissue sections according to the manufacturer's instructions (Chemicon International, Temecula, California) . Fragmented DNA was deoxygenated by terminal deoxynucleotidyl transferase. The digoxigenin was labeled with antidigoxigenin-peroxidase and visualized with DAB.
Quantitative real-time (q)PCR. Total RNA was isolated from mouse livers and reverse transcribed using the iScript cDNA Synthesis kit (Bio-Rad, Hercules, California). The cDNA was subjected to qPCR using the StepOnePlus Real-Time PCR System (Applied Biosystems, Foster City, Califronia) with AccuPower 2Â Greenstar qPCR Master Mix (Bioneer, Daejeon, Korea) according to the manufacturer's protocol. Relative gene expression levels were analyzed using the 2 ÀDDCt method and normalized against the expression of 18S rRNA. The PCR primer pair sequences are summarized in Table 1 .
Multiplex cytokine bead assay. Multiplex cytokine bead assay was performed using a customized multiplex immunoassay kit (ProcartaPlex Multiplex Immunoassay, eBioscience, Vienna, Austria) according to the manufacturer's instructions. Briefly, plasma aliquots stored at À80 C were diluted at a 1:1 ratio in the assay buffer provided in the kit. Plasma was allowed to mix with the beads coated with antibodies to 1 of TNFa, IL-1b, IL-6, IFN-c, IL-10, CXCL1, and CXCL2, and subsequently incubated with a secondary antibody that detects conjugated beadcytokine pairs. The cytokine levels were measured using the Luminex 200 System and accompanying software package xPONENT (Luminex, Austin, Texas)
Isolation of intrahepatic immune cells. Livers were collected from euthanized mice and were forced gently through a 70-lm cell strainer (BD Falcon, San Jose, California) using a sterile syringe plunger with addition of ice-cold phosphate-buffered saline (PBS). The preparation was centrifuged at 40 Â g for 5 min at 4 C. The supernatant was transferred to a new tube and centrifuged at 430 Â g for 5 min at 4 C. The pellet was re-suspended in 40% Percoll (GE Healthcare, Buckinghamshire, UK) in PBS and centrifuged at 1265 Â g with the no-brake setting for 30 min at 4 C. The supernatant was discarded and erythrocyte lysis buffer (BioLegend, San Diego, California) was added to the pellet containing the intrahepatic immune cells. The cells were washed once with Fluorescence-activated cell sorting (FACS) buffer before flow-cytometric analysis. Bone marrow-derived neutrophils. Mice were euthanized, and bone marrow was collected from femur, tibia, pelvis, scapula, and humerus. Bone marrow neutrophils were isolated by Percoll density gradient centrifugation and hypotonic lysis of red blood cells essentially as described (Mocsai et al., 2003) . Neutrophils were suspended in RPMI 1640 supplemented with 5% fetal bovine serum (FBS) and held on ice prior to testing. Neutrophil preparations were routinely >70% pure as determined by FACS (Supplementary Figure 2) .
Neutrophil chemotaxis assay. WT and Shp KO mice were injected intravenously with a sub-lethal dose (15 mg/kg) of ConA and the livers were harvested 1 h later. The livers were soaked in icecold sterile Hank's balanced salt solution supplemented with 0.5% fetal calf serum and subjected to 2 cycles of bead-beating using a TissueLyser (Qiagen, Valencia, California) followed by centrifugation. Bone marrow-derived neutrophil migration was determined using the TX ChemoTx System (101-3; NeuroProbe, Gaithersburg, Maryland) consisting of a 3-lm-pore filter in a 96-well plate. Neutrophils were prelabeled with 5 lM CellTracker Green (Molecular Probes, Eugene, Oregon). Thirty microliters of liver lysates were placed in the wells. For the CXCL2 neutralization study, liver extracts were pretreated with antimouse CXCL2 antibody (R&D Systems). The filter was transferred to the plate, and 20-ll droplets of 1.7 Â 10 6 /ml prelabeled neutrophils were placed in hydrophobic rings on the filter, which allowed contact with the liver lysates below. Additionally, a standard curve of stained cells was prepared from cell preparations, of which 30 ll was placed in separate wells and 25 ll RPMI 1640 supplemented with 5% FBS was added onto the filter top. The plate was incubated at 37 C with 5% CO 2 for 3 h. Following incubation, the medium in the top wells was absorbed, and any remaining cells were wiped off the top of the filter. The bottom plate (with the filter still on top) was centrifuged 430 Â g for 5 min. The filter was removed and 100 nM phorbol myristate acetate (Sigma-Aldrich Chemical) was added to the wells and left for 20 min to facilitate permanent adhesion of transmigrated neutrophils, after which the cells were washed with PBS. The plate was read on a Victor3 1420 Multilabel Counter (Perkin Elmer, Wellesley, Massachusetts) at 485-nm excitation and 530-nm emission wavelengths. The number of migrated cells was calculated from the standard curves, based on relative fluorescence units.
Statistical analysis. Numerical data are presented as the mean 6 SEM. Comparisons multiple groups were performed using Tukey-Kramer HSD test after the 1-way ANOVA. The survival 
ratio was analyzed using the log-rank test. The threshold of significance was set at p < .05.
RESULTS

SHP Deficiency Increases the Susceptibility to ConA-Induced Hepatitis
To investigate whether SHP affects the susceptibility of mice to ConA-induced lethality, we monitored the survival rate after challenge with a single lethal dose (25 mg/kg) of ConA. Shp KO mice showed dramatically higher mortality than WT mice ( Figure 1A ). Following the injection of ConA, there were dramatically increased mortalities in Shp KO mice. Of the Shp KO mice treated with ConA, 70% died within 12 h. Thirty-six hours following ConA administration, 47% WT mice were alive, whereas >85% of Shp KO were dead. As markers of hepatocyte injury, plasma ALT, and AST levels were measured at 0, 1, 6, and 24 h after sublethal ConA (15 mg/kg) challenge. Both were significantly higher in Shp KO mice than in WT mice at 6 and 24 h following ConA administration ( Figure 1B) . Consistent with liver function indices, Shp KO mice demonstrated more severe liver injury than WT mice, evidenced by H&E and TUNEL staining (Figs. 1C and 1D ). These results suggest that Shp KO mice are highly susceptible to ConA-induced liver damage.
Increased Liver Injury Is Independent of Cytokine Expression in Shp KO Mice Proinflammatory cytokines are key components of ConAinduced hepatitis (Kremer et al., 2008) . To define the mechanism underlying the increased susceptibility of Shp KO mice to ConA, we measured the levels of inflammatory cytokines, including TNFa, IFNc, IL-1b, IL-6, and IL-10, in liver and plasma collected from WT and Shp KO mice at different time points after ConA treatment (Figure 2) . TNFa, IFNc and IL-1b expression in the liver was substantially increased to similar levels in both groups at 1 h following ConA treatment (Figs. 2A-C). Despite increased liver injury in Shp KO mice, IL-6 expression was significantly decreased 1 h after ConA treatment ( Figure 2D ). Comparable levels of rapidly increased TNFa, the major cytokines involved in ConA-evoked liver injury, was observed in peripheral circulation of WT and Shp KO mice ( Figure 2F ). The circulating IFNc levels were similar between WT and Shp KO mice 1 h after ConA injection; however, the levels were significantly reduced in Shp KO mice after 6 h ( Figure 2G ). Plasma IL-1b, IL-6, but not IL-10 levels were elevated in Shp KO mice at later time point (Figs. 2H-J), indicating that initiation of increased liver damage in Shp KO mice is not dependent on regulation of cytokine levels.
High Susceptibility Against ConA-Induced Hepatitis in Shp KO Mice Is Accompanied by Increased Neutrophil Infiltration When liver is insulted by acute injury, rapid expansion of resident immune cells and recruitment of inflammatory cells from the circulation to the damaged area occur (Dienes et al., 1987) . To identify the phenotypes of inflammatory cells, we purified infiltrating immune cells at 3 h after ConA challenge and subjected them to FACS. Although plasma ALT and AST levels were not yet changed 3 h upon ConA treatment, immune cells had already infiltrated the liver, indicating that inflammation precedes liver injury and early proinflammatory cytokines are crucial factor for recruitment of immune cells (Figure 3 ). Infiltrated total immune cell numbers were significantly increased in liver samples of ConA-treated mice compared with PBS-treated mice liver ( Figure 3A) . However, there were no significant differences in percent population and absolute number of monocyte/macrophage and T cell between groups after ConA administration (Figs. 3B-D) .
In the present study, T cell infiltration to the injured liver was slightly increased in WT mice compared with Shp KO mice, and this elevated T cell may influence the higher levels of IFNc 6 h after ConA treatment in WT mice. Interestingly, SHP deficiency significantly enhanced neutrophil recruitment to liver after ConA administration, which was evidenced by increase of percent population and absolute number of neutrophil (Figs. 4A-C) . These findings were further confirmed by histopathology phenotyping. Immunohistochemical staining showed significantly higher neutrophil infiltration in Shp KO mice, as compared with WT mice (Figs. 4D and 4E ). To determine whether the increased susceptibility of Shp KO to ConA-induced hepatitis could be mainly mediated by neutrophil infiltration, we performed neutrophil depletion experiment using antiLy6G antibody (Figs. 4F and 4G ). As expected, control antibody treatment with ConA significantly increased plasma ALT and AST levels in Shp KO mice compared with WT mice. Upon antiLy6G antibody treatment, liver injury significantly abolished in both WT and Shp KO mice, and the differences of ALT and AST levels between control and antiLy6G antibody group were higher in Shp KO mice than those of WT mice. These data indicate that increased susceptibility to ConA-induced hepatitis in Shp KO mice is associated with accelerated neutrophil trafficking at early disease stage.
Participation of SHP on Neutrophil Recruitment Is Mediated via CXCL2
To mechanistically link SHP and neutrophil migration, we next paid attention to CXC chemokines, the pivotal drivers of neutrophil recruitment to the injured liver. (de Oliveira et al., 2016) We speculated that altered CXCL1 and/or CXCL2 levels are responsible for facilitated neutrophil migration towards liver in ConAtreated Shp KO mice. To test this, we measured the levels of CXCL1 and CXCL2 in WT and Shp KO mouse liver and plasma following ConA treatment. At the mRNA level in liver tissue, WT mice showed even higher expression of Cxcl1 than Shp KO mice ( Figure 5A ). WT and Shp KO mice showed the same pattern of circulating CXCL1 levels, which gradually increased until 6 h, then decreased until they completely disappeared at 24 h ( Figure 5C ). These results indicate that CXCL1 is not in charge of increased neutrophil infiltration in Shp KO mice. Cxcl2 expression was increased at 1 h, peaked at 6 h, and then decreased again in liver tissue of both WT and Shp KO mice, whereas its expression was consistently and significantly higher in Shp KO mice ( Figure 5B ). In line, circulating CXCL2 levels in Shp KO mice at 1 h were much higher as in WT mice ( Figure 5D ). These results strongly suggest that CXCL2 is the candidate SHP regulated parameter for increased neutrophil migration, as observed at 3 h post-ConA in liver of Shp KO mice. Furthermore, we found that also in the WT situation, Shp expression gradually decreased, while Cxcl2 expression increased until 6 h, and vice versa at 24 h upon ConAtreatment ( Figure 5E ), indicating an inverse correlation between Shp and Cxcl2 expression during ConA-induced hepatitis.
SHP Deficiency Affects Neutrophil Migration in a CXCL2-Dependent Manner
Next, to determine whether accelerated neutrophil chemotaxis after ConA-treatment is associated with CXCL2 in Shp KO mice, Figure 2 . Increased liver injury is independent of cytokine expression in Shp KO mice. A-E, WT and Shp KO mouse (n ¼ 3-4 per group) livers were collected at different time points after ConA-treatment and used for qPCR analysis of Tnfa, Ifnc, Il-1b, Il-6, and Il-10 mRNAs. Relative gene expression levels were normalized against the expression of 18 S rRNA. F-J, Multiplex cytokine bead assay of the TNFa, IFNc, IL-1b, IL-6, and IL-10 in plasma after ConA challenge. Data are means 6 SEMs. *p < .05 and ***p < .001 (Tukey-Kramer HSD test after the 1-way ANOVA).
liver lysates from ConA-treated WT and Shp KO mice were preincubated with either neutralizing antiCXCL2 monoclonal antibody or isotype control antibody and then used in a neutrophil chemotaxis assay ( Figure 6A ). As expected, neutrophil migration toward the liver lysates from ConA-treated Shp KO mice was remarkably higher than that to liver lysates from WT mice under the control antibody treatment. However, neutralization with antiCXCL2 abrogated these differences; neutrophil migration towards the neutralized liver lysates from Shp KO mice significantly decreased to a level below that towards WT-derived neutralized lysates (Figs. 6B-E) . These results would indicate that SHP deficiency affects neutrophil migration in a CXCL2-dependent manner.
CXCL2 Neutralizing Reverse Liver Injury in Shp KO Mice
Given our abovedescribed findings demonstrating that CXCL2-mediated neutrophils are major player involved in high susceptibility against ConA-induced liver injury in Shp KO mice. We next examined whether these effects can be abrogated by neutralizing of CXCL2 in vivo. For the CXCL2 neutralization study, mice were intravenously injected with antiCXCL2, or isotype control antibody 30 min before ConA-treatment. Consistent with the in vitro findings, in vivo neutralization of CXCL2 with neutralizing antibody reduce ConA-induced plasma ALT and AST levels and hepatocyte death (Figs. 7A and 7B ). Neutrophil infiltration in Shp KO mice after CXCL2 neutralization was significantly decreased (Figs. 7C and 7D) . Collectively, these results confirm that lacking of SHP results in augmented CXCL2-dependent neutrophil infiltration in ConA-induced severe liver damage.
DISCUSSION
Neutrophils are an essential component of the innate immune response and a major contributor to inflammation. Inappropriate neutrophil activation and homing to the circulation contributes to the pathology of various liver diseases, including hepatitis (Xu et al., 2014) . Here, we found that SHP deficiency promotes neutrophil migration to the liver after ConA administration; accordingly, Shp KO mice were highly susceptible to ConA-induced hepatitis.
Proinflammatory cytokines play a significant role in the induction of liver injury in ConA-mediated hepatitis (Kremer et al., 2008) . However, increased liver damage in Shp KO mice was independent of cytokines. Interestingly, circulating IL-1b was significantly increased at the later time point. IL-1b maturation is promoted by the NLRP3 inflammasome, a large multimeric protein complex that triggers caspase-1 activation, and the mature form is then secreted (Jo et al., 2016) . SHP may act as a negative regulator of NLRP3-dependent IL-1b secretion (Yang et al., 2015) . Thus, we speculate that the increased secretion of IL-1b in Shp KO mice exploits a similar mechanism. However, this assumption needs to be further investigated. In the meantime, IL-6-deficient mice are more susceptible to ConA-induced hepatitis, and IL-6-neutralizing antibody injection postConA-treatment resulted in delayed disease manifestation (Mizuhara et al., 1994; Tagawa et al., 2000) , indicating that IL-6 is hepatoprotective. In this study, hepatic expression and secretion of IL-6 were significantly increased 6 h after ConA-treatment in Shp KO mice, suggesting a preventive mechanism of the host in response to the elevated liver damage. 
SEMs. *p < .05 (Tukey-Kramer HSD test after the 1-way ANOVA).
Meanwhile, the expression and secretion of IL-10 were quite different from those of other cytokines: expression gradually increased until 24 h in Shp KO mice. IL-10 has been considered an antiinflammatory (Louis et al., 1997) and antifibrotic cytokine (Miller et al., 2011; Zhang et al., 2007) based on liver injury models, suggesting that elevated IL-10 might occur as compensatory phenomenon to protect against severe liver injury in Shp KO mice. The liver contains large resident and migratory populations of immune cells that can be rapidly expanded in response to infection or injury by recruiting immune cells from the circulation (Dienes et al., 1987) . Acute and chronic hepatitis are pathologically characterized by a prominent infiltration of immune cells into the liver . Several studies have implicated T lymphocytes as the key effector cells in ConAinduced hepatitis (Mizuhara et al., 1994; Tiegs et al., 1992; Wang et al., 2012) . However, this study has demonstrated an importance of neutrophils to initiate liver injury caused by ConA. The involvement of neutrophils in ConA hepatitis has been shown via intravital microscopic assay (Bonder et al., 2004) . In their study, Bonder et al. observed that ConA can directly bind to neutrophils, activates them, and induces a significant increase in Figure 4 . SHP deficiency promotes neutrophil migration to the injured liver during ConA-induced hepatitis. Liver immune cells were isolated at 3 h after ConA challenge followed by FACS analysis. For the identification of isolated total immune cell populations, cells were stained with fluorophore-conjugated different extracellular marker proteins: CD45, CD11b or Ly6G. A, Representative FACS images are shown. B and C, Bar graph represents the ratio of neutrophil population to the total CD45 þ subset (%) and absolute number of neutrophil. D and E, Immunohistochemistry and neutrophil count of liver samples 3 h after ConA challenge. Black arrows indicate neutrophils. Scale bar, 100 lm. MPF, medium power field. F and G, For the neutrophil depletion experiment in vivo, mice were administered with either control IgG or anti-mouse Ly6G antibody intraperitoneally at 12 h and 30 min before ConA challenge (n ¼ 6-8 per group). Plasma ALT and AST levels were measured at 9 h after ConA challenge. Data are means 6 SEMs. *p < .05, **p < .01, and ***p < .001 (Tukey-Kramer HSD test after the 1-way ANOVA).
neutrophil recruitment to the livers of mice. Moreover, they release reactive oxidants to the injured site. We observed that ConA-treatment enhanced neutrophil recruitment to the liver in Shp KO mice compared with WT mice, suggesting that neutrophils are essential for the increased susceptibility against ConA-induced hepatitis in Shp KO mice. These results suggest that control of neutrophil recruitment could have important implications for the pathogenesis of ConA-induced hepatitis.
The CXC chemokines can be divided into 2 general subgroups based upon the presence or absence of a Glu-Leu-Arg anino acid motif (ELR and nonELR) immediately preceding the first cysteine (Baggiolini, 2001) . ELR-CXC chemokines have a crucial role in neutrophil chemotaxis. The best-described ELR-CXC chemokines in mice are CXCL1 and CXCL2, which are regarded functionally analogous to human IL-8 and rat neutrophil-chemoattractant (Rot and von Andrian, 2004) . The involvement of these chemokines in neutrophil-dependent inflammatory diseases was demonstrated by the use of neutralizing antibodies, and is now widely accepted (Ha et al., 2011; Nabah et al., 2004; Riaz et al., 2003; Roche et al., 2007) In this study, we verified that in Shp KO mice, inflammatory signals released from the liver guide the trafficking of high numbers of circulating neutrophils into the injured liver. In vivo and in vitro results of neutralization study with antiCXCL2 monoclonal antibodies indicate that the enhanced neutrophil trafficking in Shp KO mice is CXCL2-dependent. Moreover, Shp expression was inversely correlated with Cxcl2 expression in ConA-treated liver, implying the possibility of SHP as a regulator of CXCL2.
We have verified cell type-specific roles of SHP on CXCL2 regulation in liver. We isolated Kupffer cells and primary hepatocytes from liver of WT and Shp KO mice. The isolated Kupffer cells and hepatocytes were treated with ConA and TNFa, which is major cytokine produced early in liver inflammation, respectively. Cxcl2 expression was remarkably elevated by ConAtreatment in Kupffer cells from both WT and Shp KO mice, but the increased levels were comparable between WT and Shp KO mice. Meanwhile, Cxcl2 expression was largely up-regulated in SHP-deficient hepatocytes after TNFa treatment compared with WT hepatocytes (Supplementary Figure 3) . These results would suggest that hepatocytes are the major source for increased CXCL2 production followed by elevated neutrophil infiltration in liver of Shp KO mice after ConA-treatment.
Finally, we examined how Cxcl2 expression was regulated by SHP in the liver during the progression of ConA-induced hepatitis. A previous study reported that CXCL2 is transcriptionally regulated by both c-Jun/Activator Protein-1 (AP-1) and NFjB (Orlichenko et al., 2010) . Western blot analysis showed that phosphorylation of p65 and MKK4/JNK/c-jun was comparable at 1 h after ConA-treatment in both WT and Shp KO mouse livers (Supplementary Figure 4A) . Nevertheless, hepatic expression of CXCL2 in Shp KO mice was much higher at that time point than in WT mice. Moreover, TNFa-treated primary hepatocytes isolated from WT or Shp KO mice did not show any differences in these pathways (Supplementary Figure 4B) . These results indicated that SHP modulates CXCL2 transcription through another pathway. Further studies are needed to find the underlying mechanism for SHP on regulation of CXCL2 expression.
Collectively, our data clearly indicated that SHP deficiency increases the expression of CXCL2 to promote neutrophil trafficking followed by severe liver injury. Thus, SHP plays a protective and an anti-inflammatory role in liver during acute liver inflammation. Upregulation of SHP may be used as a therapeutic modality against controlling inflammatory liver diseases.
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